ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 1 filers reported holding ARIAD PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,375,000 | +4.6% | 190,900 | +15.1% | 1.33% | -41.1% |
| Q3 2016 | $2,271,000 | +458.0% | 165,900 | +201.1% | 2.26% | +323.0% |
| Q2 2016 | $407,000 | -46.9% | 55,100 | -54.1% | 0.54% | -49.1% |
| Q1 2016 | $767,000 | -33.7% | 120,100 | -35.1% | 1.05% | +47.1% |
| Q4 2015 | $1,157,000 | -5.7% | 185,100 | -11.9% | 0.72% | -37.9% |
| Q3 2015 | $1,227,000 | -51.4% | 210,100 | -31.1% | 1.15% | -26.6% |
| Q2 2015 | $2,523,000 | -1.3% | 305,100 | -1.6% | 1.57% | -8.0% |
| Q1 2015 | $2,555,000 | +27.3% | 310,100 | +6.1% | 1.70% | +57.9% |
| Q4 2014 | $2,007,000 | +36.5% | 292,200 | +7.3% | 1.08% | +3.9% |
| Q3 2014 | $1,470,000 | -14.5% | 272,200 | +0.8% | 1.04% | -2.9% |
| Q2 2014 | $1,720,000 | -23.1% | 270,100 | -2.7% | 1.07% | -11.4% |
| Q1 2014 | $2,237,000 | -60.7% | 277,600 | -66.8% | 1.21% | -56.1% |
| Q4 2013 | $5,695,000 | – | 835,100 | – | 2.75% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
| Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
| Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
| Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
| Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
| Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
| Geduld E E | 272,200 | $1,470,000 | 1.04% |
| Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
| Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
| HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |